These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
93 related articles for article (PubMed ID: 219889)
21. Differential effects of thyrotropin-releasing hormone, vasoactive intestinal peptide, phorbol ester, and depolarization in GH4C1 rat pituitary cells. Aizawa T; Hinkle PM Endocrinology; 1985 Mar; 116(3):909-19. PubMed ID: 3918848 [TBL] [Abstract][Full Text] [Related]
22. Bihormonal regulation of the thyrotropin-releasing hormone receptor in mouse pituitary thyrotropic tumor cells in culture. Gershengorn MC J Clin Invest; 1978 Nov; 62(5):937-43. PubMed ID: 213447 [TBL] [Abstract][Full Text] [Related]
23. Pituitary thyrotropin-releasing hormone receptors: local anesthetic effects on binding and responses. Phillips WJ; Enyeart JJ; Hinkle PM Mol Endocrinol; 1989 Sep; 3(9):1345-51. PubMed ID: 2558307 [TBL] [Abstract][Full Text] [Related]
24. Correlative studies between the presence of thyrotropin-releasing hormone (TRH) receptors and the in vitro stimulation of growth-hormone (GH) secretion in human GH-secreting adenomas. Le Dafniet M; Garnier P; Bression D; Brandi AM; Racadot J; Peillon F Horm Metab Res; 1985 Sep; 17(9):476-9. PubMed ID: 2864309 [TBL] [Abstract][Full Text] [Related]
25. Degradation of thyrotropin-releasing hormone by the GH3 strain of pituitary cells in culture. Hinkle PM; Tashjian AH Endocrinology; 1975 Aug; 97(2):324-31. PubMed ID: 169122 [TBL] [Abstract][Full Text] [Related]
27. Transient dopaminergic inhibition of prolactin release from hybrid cells derived by fusion of normal rat pituitary and GH4C1 tumor cells. Day RN; Hinkle PM Endocrinology; 1988 May; 122(5):2165-73. PubMed ID: 3129281 [TBL] [Abstract][Full Text] [Related]
28. [Radio-receptor assay for thyrotropin releasing hormone (author's transl)]. Faivre-Bauman A; Gourdji D; Tixier-Vidal A Ann Endocrinol (Paris); 1977; 38(4):265-71. PubMed ID: 197873 [TBL] [Abstract][Full Text] [Related]
29. The coumarin osthol attenuates the binding of thyrotropin-releasing hormone in rat pituitary GH4C1 cells. Ojala T; Vuorela P; Vuorela H; Törnquist K Planta Med; 2001 Apr; 67(3):236-9. PubMed ID: 11345694 [TBL] [Abstract][Full Text] [Related]
30. Thyrotropin releasing hormone (TRH): apparent receptor binding in rat brain membranes. Burt DR; Snyder SH Brain Res; 1975 Aug; 93(2):309-28. PubMed ID: 169955 [TBL] [Abstract][Full Text] [Related]
31. Characterization of the calcium response to thyrotropin-releasing hormone (TRH) in cells transfected with TRH receptor complementary DNA: importance of voltage-sensitive calcium channels. Li P; Thaw CN; Sempowski GD; Gershengorn MC; Hinkle PM Mol Endocrinol; 1992 Sep; 6(9):1393-402. PubMed ID: 1279382 [TBL] [Abstract][Full Text] [Related]
32. Mechanism of thyroid hormone inhibition of thyrotropin-releasing hormone action. Hinkle PM; Perrone MH; Schonbrunn A Endocrinology; 1981 Jan; 108(1):199-205. PubMed ID: 6257485 [TBL] [Abstract][Full Text] [Related]
33. Evidence of receptors for thyrotropin-releasing hormone in human prolactin-secreting adenomas. Le Dafniet M; Brandi AM; Bression D; Racadot T; Peillon F J Clin Endocrinol Metab; 1983 Aug; 57(2):425-7. PubMed ID: 6306043 [TBL] [Abstract][Full Text] [Related]
34. Thapsigargin, but not caffeine, blocks the ability of thyrotropin-releasing hormone to release Ca2+ from an intracellular store in GH4C1 pituitary cells. Law GJ; Pachter JA; Thastrup O; Hanley MR; Dannies PS Biochem J; 1990 Apr; 267(2):359-64. PubMed ID: 1692207 [TBL] [Abstract][Full Text] [Related]
35. Pituitary thyrotropin-releasing hormone (TRH) receptors: effects of TRH, drugs mimicking TRH action, and chlordiazepoxide. Hinkle PM; Shanshala ED Mol Endocrinol; 1989 Sep; 3(9):1337-44. PubMed ID: 2481818 [TBL] [Abstract][Full Text] [Related]
36. Regulation of endogenous thyrotropin-releasing hormone (TRH) receptor messenger RNA by TRH in GH4C1 cells. Yang J; Tashjian AH Mol Endocrinol; 1993 Jun; 7(6):753-8. PubMed ID: 8395652 [TBL] [Abstract][Full Text] [Related]
37. Effects of cholera toxin on the coupling of thyrotropin-releasing hormone to a guanine nucleotide-binding protein in cultured GH3 cells. Yajima Y; Akita Y; Saito T Mol Pharmacol; 1988 Jun; 33(6):592-7. PubMed ID: 2837635 [TBL] [Abstract][Full Text] [Related]
38. Kinetics and reversibility of thyrotropin-releasing hormone-stimulated guanine nucleotide exchange in membranes from GH4C1 cells. Brady KD; Han B; Tashjian AH Mol Pharmacol; 1994 Oct; 46(4):644-52. PubMed ID: 7969042 [TBL] [Abstract][Full Text] [Related]
39. Thyrotropin-releasing hormone stimulation of adrenocorticotropin production by mouse pituitary tumor cells in culture: possible model for anomalous release of adrenocorticotropin by thyrotropin-releasing hormone in some patients with Cushing's disease and Nelson's syndrome. Gershengorn MC; Arevalo CO; Geras E; Rebecchi MJ J Clin Invest; 1980 Jun; 65(6):1294-300. PubMed ID: 6251109 [TBL] [Abstract][Full Text] [Related]
40. Effects of lipid fluidity on quenching characteristics of tryptophan fluorescence in yeast plasma membrane. Esfahani M; Devlin TM J Biol Chem; 1982 Sep; 257(17):9919-21. PubMed ID: 7050112 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]